Rise in cases of venous thromboembolism and cardiovascular disorders increase in number of patients undergoing such surgeries, and surge in geriatric population

PORTLAND, OR, UNITED STATES, August 23, 2021 /EINPresswire.com/ -- Surge in incidence of venous thromboembolism and cardiovascular disorders, rise in use of heparin in surgical procedures, and increase in geriatric populations drive the growth of the global heparin market. However, side effects associated with heparin and presence of alternative anticoagulants hinder the market growth. On the contrary, availability of synthetic and semi-synthetic heparin mimetics and R&D activities to develop heparin with improved therapeutics are expected to create lucrative opportunities for the market players in the future.

“Heparin Market by Product, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021–2028," the global heparin market size was valued at $6,535 million in 2020, and is projected to reach $11,015 million by 2028, registering a CAGR of 6.6% from 2021 to 2028.

Download Free Sample Report at: https://www.alliedmarketresearch.com/request-sample/6551

Surge in incidence of venous thromboembolism and cardiovascular disorders, rise in use of heparin in surgical procedures, and increase in geriatric populations drive the growth of the global heparin market. The market across Asia-Pacific is projected to portray the highest CAGR of 7.8% during the forecast period. The heparin market witnessed a modest growth during the pandemic due to rise in use of low molecular weight heparin for Covid-19 treatment.

Covid-19 scenario:

1) The heparin market witnessed a modest growth during the pandemic due to rise in use of low molecular weight heparin for Covid-19 treatment.

2) A large number of patients are suffering from Covid-19 which is linked to respiratory disease. The demand for heparin has increased as it helps to control respiratory inflation and acts as a blood thinner.

The global heparin market is segmented on the basis of product, application, distribution channel, and region. Based on product, the low molecular weight heparin segment held the lion’s share in 2020, accounting for more than four-fifths of the market. Moreover, the segment is expected to register the highest CAGR of 6.9% during the forecast period.

On the basis of application, the venous thromboembolism segment dominated in 2020, contributing to more than two-fifths of the market. However, the coronary artery disease segment is expected to manifest the highest CAGR of 7.3% from 2021 to 2028.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/6551

The global heparin market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across Asia-Pacific is projected to portray the highest CAGR of 7.8% during the forecast period. However, the market across Europe held the largest share in 2020, accounting for nearly half of the market.

The global heparin market includes an in-depth analysis of the prime market players such as B. Braun Holding GmbH & Co. KG, Baxter International Inc., Fresenius SE & Co KGaA, Dr. Reddy’s Laboratories Ltd., Leo Pharma A/S, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Pfizer Inc., Sanofi S.A, Teva Pharmaceuticals, and Viatris Inc.

Trending Reports in Industry:

Clinical Nutrition Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

AR In Healthcare Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+15034461141 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn